Novavax Inc (NASDAQ:NVAX)

7.95
Delayed Data
As of May 01
 +0.22 / +2.85%
Today’s Change
3.80
Today|||52-Week Range
9.95
+34.06%
Year-to-Date

Today’s Trading

Previous close7.73
Today’s open7.83
Day’s range7.69 - 7.96
Volume3,544,858
Average volume (3 months)4,671,999
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)-19.35%
Earnings growth (this year)-27.04%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+46.59%
P/E ratioNM
Price/Sales43.68
Price/Book8.27

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...+5.27+5.54%
HALOHalozyme Therapeutic...+0.92+6.19%
KITEKite Pharma Inc+1.03+2.04%
OPHTOphthotech Corp+0.70+1.55%
Data as of 3:59pm ET, 05/01/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$30.7M
Annual profit (last year)-$82.9M
Net profit margin-270.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers